TAL Education
TAL
12.76
+0.16
+1.27%
TAL Education
US · TAL
#1827 by market cap
Listed 2010
12.76
+0.16
+1.27%
Live - 5344 symbols - heartbeat 382s ago
· 2026-10-08 04:07
Pre-market
12.70
-0.47%
After-hours
12.76
-0.02%
Overnight
12.69
-0.55%
- Market cap
- 7.08B
- P/E (TTM)i
- 7.99
- P/Bi
- 1.73
- EPSi
- 0.92
- Div yieldi
- 0.00%
- 52W posi
- 86%
Reader sentiment
Are you bullish or bearish on TAL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.01, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +33.72% YoY
Margins
- Gross margin
- 55.35%
- Operating margin
- 9.17%
- Net margin
- 17.64%
Key ratios & quality
- Altman Z-Scorei
- 3.01
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.56B | 3.27B | 4.50B | 4.39B | 1.02B | 1.49B | 2.25B | 3.01B |
| Gross profit | 1.40B | 1.80B | 2.45B | 2.19B | 583.41M | 806.12M | 1.20B | 1.67B |
| Selling & admin expenses | 1.06B | 1.65B | 2.80B | 2.32B | 696.83M | 875.35M | 1.20B | 1.39B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 341.58M | 166.44M | -330.69M | -109.47M | -90.73M | -69.23M | -3.16M | 276.04M |
| Pretax profit | 457.20M | -50.65M | -224.62M | -778.13M | -109.72M | 17.48M | 132.11M | 685.41M |
| Tax | 76.50M | 69.33M | -69.90M | 396.99M | 20.01M | 15.38M | 38.32M | 154.42M |
| Net profit | 364.51M | -127.65M | -143.05M | -1.16B | -131.98M | -4.14M | 84.26M | 530.14M |
| Basic EPS | 1 | 0 | 0 | -2 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.61 | -0.19 | -0.19 | -1.76 | -0.21 | -0.01 | 0.14 | 0.92 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Revenue | 610.24M | 575.00M | 861.35M | 770.17M | 802.39M | 758.38M |
| Gross profit | 317.59M | 315.43M | 491.01M | 431.81M | 427.23M | 438.20M |
| Selling & admin expenses | 333.61M | 301.08M | 396.39M | 338.68M | 354.76M | 301.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -16.02M | 14.35M | 96.10M | 93.12M | 72.47M | 137.20M |
| Pretax profit | 11.77M | 42.54M | 175.92M | 146.04M | 320.90M | 552.32M |
| Tax | 13.97M | 11.08M | 51.08M | 15.31M | 76.95M | 143.66M |
| Net profit | -7.40M | 31.21M | 124.03M | 130.52M | 244.39M | 407.93M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | -0.01 | 0.05 | 0.21 | 0.23 | 0.44 | 0.73 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.75B | 2.50B | 8.16B | 3.63B | 3.47B | 3.70B | 4.13B | 3.84B |
| Cash & ST investments | 1.52B | 2.22B | 5.94B | 2.71B | 3.17B | 3.30B | 3.62B | 3.24B |
| Inventory | 7.75M | 25.83M | 38.68M | 21.83M | 39.00M | 68.33M | 104.88M | 143.33M |
| Total assets | 3.74B | 5.57B | 12.11B | 5.08B | 4.72B | 4.93B | 5.50B | 5.94B |
| Total current liabilities | 1.18B | 1.81B | 3.37B | 902.58M | 783.87M | 1.08B | 1.44B | 1.77B |
| Short-term debt | 215.30M | 304.96M | 652.67M | 66.11M | 42.17M | 62.60M | 88.45M | 109.39M |
| Long-term debt | -- | 261.95M | 2.30B | -- | -- | -- | -- | -- |
| Total liabilities | 1,204,614,000.00 | 3,027,049,000.00 | 6,907,753,000.00 | 1,080,266,000.00 | 903,441,000.00 | 1,289,185,000.00 | 1,736,669,000.00 | 2,162,603,000.00 |
| Total equity | 2.53B | 2.54B | 5.20B | 4.00B | 3.82B | 3.64B | 3.77B | 3.77B |
| Retained earnings | 920.31M | 786.10M | 624.88M | -544.31M | -685.91M | -694.27M | -624.08M | -130.43M |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Total current assets | 4.13B | 4.10B | 3.85B | 4.31B | 3.84B | 3.69B |
| Cash & ST investments | 3.62B | 3.47B | 3.25B | 3.62B | 3.24B | 2.87B |
| Inventory | 104.88M | 136.98M | 133.02M | 136.95M | 143.33M | 184.82M |
| Total assets | 5.50B | 5.72B | 5.45B | 5.92B | 5.94B | 6.77B |
| Total current liabilities | 1.44B | 1.83B | 1.69B | 2.08B | 1.77B | 2.18B |
| Short-term debt | 88.45M | 98.47M | 103.78M | 104.32M | 109.39M | 118.81M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,736,669,000.00 | 2,144,951,000.00 | 2,017,141,000.00 | 2,420,950,000.00 | 2,162,603,000.00 | 2,688,927,000.00 |
| Total equity | 3.77B | 3.57B | 3.44B | 3.50B | 3.77B | 4.08B |
| Retained earnings | -624.08M | -591.20M | -466.41M | -334.54M | -130.43M | 281.57M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 194.36M | 855.85M | 954.73M | -939.18M | 7.36M | 306.17M | 397.92M | 601.47M |
| Depreciation & amortization | 88.84M | 117.99M | 165.34M | 189.86M | 40.70M | 29.87M | 52.30M | 76.72M |
| Free cash flow | -160.65M | 667.79M | 708.99M | -1.19B | -102.97M | 184.88M | 285.45M | 507.89M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 500.00M | 0 | 2.49B | -196.28M | -66.37M | -233.56M | -13.15M | -644.09M |
| Ending cash balance | 1.26B | 1.92B | 5.02B | 2.68B | 2.29B | 2.46B | 1.99B | 1.79B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Operating cash flow | -226.33M | 347.79M | -58.10M | 526.74M | -214.97M | 478.24M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -338.80M | 347.79M | -58.10M | 526.74M | -308.54M | 478.24M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.99B | 1.56B | 1.78B | 2.49B | 1.79B | 1.95B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.89 | -4.41 | -3.01 | -24.61 | -3.44 | -0.10 | 2.28 | 14.08 |
| ROA %i | 10.82 | -2.37 | -1.31 | -13.21 | -2.77 | -0.07 | 1.62 | 9.28 |
| ROIC %i | 14.65 | -3.93 | -2.74 | -17.73 | -4.39 | -1.70 | 0.63 | 11.68 |
| 5-year avg ROE %i | 21.58 | 16.01 | 9.92 | 0.68 | -3.52 | -7.11 | -5.78 | -2.36 |
| EBIT margin %i | 18.53 | -1.19 | -4.62 | -17.54 | -10.76 | 1.17 | -0.14 | 9.17 |
| FCF / sales %i | -- | 20.40 | 15.77 | -- | -- | 12.40 | 12.69 | 16.88 |
| Current ratioi | 1.47 | 1.38 | 2.42 | 4.02 | 4.42 | 3.42 | 2.86 | 2.17 |
| Quick ratioi | 1.37 | 1.31 | 1.81 | 3.08 | 4.15 | 3.13 | 2.58 | 1.88 |
| Debt / assetsi | 5.76 | 27.23 | 34.23 | 4.76 | 3.34 | 4.85 | 6.06 | 6.53 |
| LT debt / equityi | -- | 48.17 | 67.16 | 4.37 | 3.01 | 4.82 | 6.50 | 7.37 |
| Interest coveragei | 26.94 | -3.29 | -12.26 | -97.86 | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 60.50 | 46.40 | 37.88 | 19.66 | -32.21 | -30.79 | -19.98 | 43.43 |
| Net income CAGR (3Y) %i | 52.83 | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | 29.44 | 8.38 | -- | -- | -36.11 | -- | -- |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| ROE %i | 2.28 | 2.88 | 4.76 | 7.66 | 14.08 | 23.72 |
| ROA %i | 1.62 | 1.90 | 3.17 | 4.76 | 9.28 | 14.54 |
| ROIC %i | 0.63 | 1.21 | 3.00 | 5.69 | 11.68 | 20.57 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.14 | 1.18 | 2.90 | 6.66 | 9.17 | 12.50 |
| FCF / sales %i | 12.69 | 16.04 | 12.41 | 16.96 | 16.88 | 20.00 |
| Current ratioi | 2.86 | 2.25 | 2.28 | 2.07 | 2.17 | 1.69 |
| Quick ratioi | 2.58 | 1.90 | 1.92 | 1.74 | 1.88 | 1.32 |
| Debt / assetsi | 6.06 | 6.54 | 6.85 | 6.37 | 6.53 | 5.99 |
| LT debt / equityi | 6.50 | 7.71 | 7.85 | 7.80 | 7.37 | 7.03 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 04:07:18 · For reference only, not investment advice and not tailored to your situation.